D
Dierk Scheinert
Researcher at Leipzig University
Publications - 242
Citations - 17521
Dierk Scheinert is an academic researcher from Leipzig University. The author has contributed to research in topics: Angioplasty & Stent. The author has an hindex of 58, co-authored 224 publications receiving 15085 citations. Previous affiliations of Dierk Scheinert include University of Erlangen-Nuremberg & Universidade Federal do Vale do São Francisco.
Papers
More filters
Journal ArticleDOI
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler,Henry Krum,Paul A. Sobotka,Markus P. Schlaich,Roland E. Schmieder,Michael Böhm,Felix Mahfoud,Horst Sievert,Nina Wunderlich,Lars Christian Rump,Oliver Vonend,Michael Uder,Mel Lobo,Mark J. Caulfield,Andrejs Erglis,Michel Azizi,Marc Sapoval,S. Thambar,Alexandre Persu,Jean Renkin,Heribert Schunkert,Joachim Weil,Uta C. Hoppe,Tony Walton,Dierk Scheinert,Thomas Binder,Andrzej Januszewicz,Adam Witkowski,Luis M. Ruilope,Robert Whitbourn,Heike Bruck,Mark Downes,Thomas F. Lüscher,Alan G. Jardine,Mark Webster,Thomas Zeller,Jerzy Sadowski,Krzysztof Bartus,Craig A. Straley,Neil C. Barman,David P. Lee,Ronald M. Witteles,Vivek Bhalla,Joseph M. Massaro +43 more
TL;DR: Catheter-based renal denervation can safely be used to substantially reduce blood pressure in treatment-resistant hypertensive patients and should be continued, according to the authors.
Journal ArticleDOI
Endovascular Repair of Type B Aortic Dissection Long-Term Results of the Randomized Investigation of Stent Grafts in Aortic Dissection Trial
Christoph A. Nienaber,Stephan Kische,Hervé Rousseau,Holger Eggebrecht,Tim C. Rehders,Guenther Kundt,Aenne Glass,Dierk Scheinert,Martin Czerny,Tilo Kleinfeldt,Burkhart Zipfel,Louis Labrousse,Rossella Fattori,Hüseyin Ince +13 more
TL;DR: In this study of survivors of type B aortic dissection, TEVAR in addition to optimal medical treatment is associated with improved 5-year aorta-specific survival and delayed disease progression and should be considered to improve late outcome.
Journal ArticleDOI
Prevalence and clinical impact of stent fractures after femoropopliteal stenting.
Dierk Scheinert,Susanne Scheinert,Jacqueline Sax,Christopher Piorkowski,Sven Bräunlich,Matthias Ulrich,Giancarlo Biamino,Andrej Schmidt +7 more
TL;DR: There is a considerable risk of stent fractures after long segment femoral artery stenting, which is associated with a higher in-stent restenosis and reocclusion rate.
Journal ArticleDOI
Randomized Comparison of Strategies for Type B Aortic Dissection The INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) Trial
Christoph A. Nienaber,Hervé Rousseau,Holger Eggebrecht,Stephan Kische,Rossella Fattori,Tim C. Rehders,Gunther Kundt,Dierk Scheinert,Martin Czerny,Tilo Kleinfeldt,Burkhart Zipfel,Louis Labrousse,Hüseyin Ince +12 more
TL;DR: In the first randomized study on elective stent-graft placement in survivors of uncomplicated type B aortic dissection, TEVAR failed to improve 2-year survival and adverse event rates despite favorable aorti remodeling.
Journal ArticleDOI
Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery Twelve-Month Results From the RESILIENT Randomized Trial
John R. Laird,Barry T. Katzen,Dierk Scheinert,Johannes Lammer,Jeffrey S Carpenter,Maurice Buchbinder,Rajesh Dave,Gary M. Ansel,Alexandra J. Lansky,Ecaterina Cristea,Tyrone J. Collins,Jeffrey Goldstein,Michael R. Jaff +12 more
TL;DR: In this article, a total of 206 patients from 24 centers in the United States and Europe with obstructive lesions of the superficial femoral artery and proximal popliteal artery and intermittent claudication were randomized to implantation of nitinol stents or percutaneous transluminal angioplasty.